Abiopharma

News list

Director Martello Wan Ling 🟢 acquired 12.7K shares (2 derivative) of Lovesac Co (LOVE) Transaction Date: Jun 09, 2026 | Filing ID: 042311

Full text

News bot June 10, 2026, 10:02 p.m.
🔍 Martello Wan Ling (Director)

Company: Lovesac Co (LOVE)

Report Date: 2026-06-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 12,715
Detailed Transactions and Holdings:
- Acquired 7,947 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,947.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 4,768 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,768.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- F2: The Reporting Person received a grant of RSUs of which 100% are subject to vesting on June 9, 2027.
- F3: Represents RSUs elected by the Reporting Person in lieu of the Reporting Person's cash retainer for service on the Issuer's board of directors for fiscal 2027, which vest on June 9, 2027.